Financial Ratios B-SOFT Co.,Ltd.
Equities
300451
CNE100001ZG7
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.480 CNY | -1.62% |
|
-0.54% | +13.22% |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.09 | 4.72 | 1.46 | 0.64 | -1.51 | |||||
Return on Total Capital | 6.27 | 5.72 | 1.78 | 0.79 | -1.87 | |||||
Return On Equity % | 9.89 | 9.44 | 0.9 | 0.99 | -3.66 | |||||
Return on Common Equity | 9.88 | 9.49 | 0.93 | 0.8 | -3.85 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 55.38 | 54.14 | 49.23 | 46.64 | 43.39 | |||||
SG&A Margin | 20.75 | 17.93 | 20.02 | 20.85 | 23.19 | |||||
EBITDA Margin % | 23.72 | 22.97 | 10.34 | 5.23 | -7.45 | |||||
EBITA Margin % | 22.49 | 21.97 | 9.2 | 4.12 | -9.2 | |||||
EBIT Margin % | 22.06 | 21.59 | 8.72 | 3.67 | -9.71 | |||||
Income From Continuing Operations Margin % | 20.59 | 21.81 | 2.7 | 2.83 | -11.76 | |||||
Net Income Margin % | 20.35 | 21.75 | 2.79 | 2.27 | -12.2 | |||||
Net Avail. For Common Margin % | 20.35 | 21.75 | 2.79 | 2.27 | -12.2 | |||||
Normalized Net Income Margin | 13.89 | 15.06 | 6.11 | 2.58 | -4.81 | |||||
Levered Free Cash Flow Margin | 1.33 | -6.64 | -12.08 | -22.85 | -10.84 | |||||
Unlevered Free Cash Flow Margin | 1.57 | -6.59 | -11.94 | -22.81 | -10.79 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.37 | 0.35 | 0.27 | 0.28 | 0.25 | |||||
Fixed Assets Turnover | 5.38 | 5.6 | 3.71 | 3.04 | 2.56 | |||||
Receivables Turnover (Average Receivables) | 1.81 | 1.63 | 1.05 | 1.01 | 0.85 | |||||
Inventory Turnover (Average Inventory) | 3.11 | 3.08 | 3.08 | 3.16 | 2.56 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.92 | 3.33 | 2.82 | 2.84 | 2.6 | |||||
Quick Ratio | 2.57 | 3.07 | 2.58 | 2.56 | 2.3 | |||||
Operating Cash Flow to Current Liabilities | 0.25 | 0.18 | 0.12 | 0.14 | 0.1 | |||||
Days Sales Outstanding (Average Receivables) | 202.1 | 223.5 | 347.49 | 362.49 | 432.09 | |||||
Days Outstanding Inventory (Average Inventory) | 117.85 | 118.62 | 118.44 | 115.54 | 143.11 | |||||
Average Days Payable Outstanding | 128.82 | 205.42 | 268.69 | 274.02 | 293.13 | |||||
Cash Conversion Cycle (Average Days) | 191.13 | 136.7 | 197.24 | 204.02 | 282.07 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 4.02 | 0.42 | 2.48 | 0.48 | 1.37 | |||||
Total Debt / Total Capital | 3.86 | 0.42 | 2.42 | 0.48 | 1.35 | |||||
LT Debt/Equity | - | 0.15 | 0.06 | 0.19 | 0.15 | |||||
Long-Term Debt / Total Capital | - | 0.15 | 0.06 | 0.19 | 0.15 | |||||
Total Liabilities / Total Assets | 20.43 | 18.01 | 20.43 | 19.45 | 21.08 | |||||
EBIT / Interest Expense | 58.24 | 282.25 | 41.65 | 51.39 | -111.43 | |||||
EBITDA / Interest Expense | 62.6 | 305.72 | 51.92 | 78.08 | -80.6 | |||||
(EBITDA - Capex) / Interest Expense | 29.45 | 174.52 | -48.09 | -261.48 | -276.48 | |||||
Total Debt / EBITDA | 0.43 | 0.04 | 0.69 | 0.25 | -0.62 | |||||
Net Debt / EBITDA | -4.13 | -3.6 | -8.22 | -12.12 | 9.71 | |||||
Total Debt / (EBITDA - Capex) | 0.92 | 0.08 | -0.74 | -0.07 | -0.18 | |||||
Net Debt / (EBITDA - Capex) | -8.78 | -6.31 | 8.87 | 3.62 | 2.83 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 10.34 | 16.3 | -19.58 | 5.81 | -11.96 | |||||
Gross Profit, 1 Yr. Growth % | 14.45 | 13.69 | -26.87 | 0.24 | -18.1 | |||||
EBITDA, 1 Yr. Growth % | 14.72 | 7.19 | -66.14 | -59.54 | -175.24 | |||||
EBITA, 1 Yr. Growth % | 15.4 | 7.85 | -68.61 | -65.21 | -206.48 | |||||
EBIT, 1 Yr. Growth % | 17.49 | 13.81 | -67.52 | -55.47 | -562.73 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 5.5 | 23.17 | -90.03 | 10.79 | -466.26 | |||||
Net Income, 1 Yr. Growth % | 5.82 | 24.28 | -89.68 | -13.93 | -572.96 | |||||
Normalized Net Income, 1 Yr. Growth % | 6.87 | 26.08 | -67.34 | -55.43 | -394.82 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 0 | 22.73 | -88.89 | -33.33 | -650 | |||||
Accounts Receivable, 1 Yr. Growth % | 6.21 | 50.34 | 8.12 | 12.57 | -2.73 | |||||
Inventory, 1 Yr. Growth % | 126.66 | -26.12 | 9.21 | 7.84 | 22.37 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 7.1 | 16.24 | 25.81 | 31.28 | -15.53 | |||||
Total Assets, 1 Yr. Growth % | 46.23 | 6.87 | 3.1 | 0.12 | -2.11 | |||||
Tangible Book Value, 1 Yr. Growth % | 112.58 | 12.77 | -3.69 | -2.16 | -3.82 | |||||
Common Equity, 1 Yr. Growth % | 59.85 | 10.2 | 0.7 | 0.27 | -4.05 | |||||
Cash From Operations, 1 Yr. Growth % | 238.49 | -35.05 | -17.79 | 8.95 | -27.31 | |||||
Capital Expenditures, 1 Yr. Growth % | 70.73 | -7.07 | 67.76 | 22.56 | -38.05 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -142.51 | 1.3K | 34.95 | 100.23 | -62.85 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -155.6 | 2.33K | 34.38 | 102.03 | -62.97 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 29.87 | -66.67 | 0 | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 12.49 | 13.28 | -3.29 | -7.75 | -3.48 | |||||
Gross Profit, 2 Yr. CAGR % | 18.7 | 14.07 | -8.82 | -14.38 | -9.39 | |||||
EBITDA, 2 Yr. CAGR % | 20.07 | 13.67 | -37.71 | -57.44 | -28.77 | |||||
EBITA, 2 Yr. CAGR % | 21.06 | 14.5 | -39.75 | -61.43 | -17.29 | |||||
EBIT, 2 Yr. CAGR % | 21.45 | 15.63 | -39.2 | -61.97 | 1.83 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 23.6 | 13.99 | -64.96 | -66.79 | 101.44 | |||||
Net Income, 2 Yr. CAGR % | 25 | 14.68 | -64.18 | -70.2 | 101.76 | |||||
Normalized Net Income, 2 Yr. CAGR % | 24.78 | 16.08 | -35.83 | -61.84 | -14.41 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 22.49 | 10.01 | -63.07 | -72.78 | 91.49 | |||||
Accounts Receivable, 2 Yr. CAGR % | 26.37 | 26.37 | 27.49 | 10.32 | 4.64 | |||||
Inventory, 2 Yr. CAGR % | 92.91 | 29.4 | -10.18 | 8.52 | 14.88 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -6.63 | 11.57 | 20.93 | 28.52 | 5.31 | |||||
Total Assets, 2 Yr. CAGR % | 30.58 | 25.01 | 4.97 | 1.6 | -1 | |||||
Tangible Book Value, 2 Yr. CAGR % | 54.41 | 54.83 | 4.21 | -2.93 | -2.99 | |||||
Common Equity, 2 Yr. CAGR % | 33.55 | 32.72 | 5.34 | 0.48 | -1.92 | |||||
Cash From Operations, 2 Yr. CAGR % | 26.45 | 48.27 | -26.93 | -5.36 | -11.01 | |||||
Capital Expenditures, 2 Yr. CAGR % | 35.49 | 25.96 | 24.86 | 43.39 | -12.86 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -35.22 | 56.79 | 352.07 | 64.38 | -8.54 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -24.62 | 64.66 | 494.73 | 64.77 | -8.27 | |||||
Dividend Per Share, 2 Yr. CAGR % | 16.23 | 13.96 | -34.2 | -42.26 | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 12.3 | 13.75 | 1.05 | -0.35 | -9.18 | |||||
Gross Profit, 3 Yr. CAGR % | 17.03 | 17.01 | -1.64 | -5.89 | -15.64 | |||||
EBITDA, 3 Yr. CAGR % | 23.3 | 17.53 | -22.37 | -40.79 | -38.98 | |||||
EBITA, 3 Yr. CAGR % | 24.78 | 18.53 | -23.87 | -44.38 | -33.62 | |||||
EBIT, 3 Yr. CAGR % | 24.86 | 18.85 | -24.27 | -45.2 | -30.43 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 25.83 | 23.46 | -49.41 | -48.59 | -26.07 | |||||
Net Income, 3 Yr. CAGR % | 26.74 | 24.76 | -48.6 | -52.03 | -25.1 | |||||
Normalized Net Income, 3 Yr. CAGR % | 25.65 | 25.21 | -23.94 | -43.17 | -37.92 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 23.07 | 22 | -48.77 | -55.04 | -25.87 | |||||
Accounts Receivable, 3 Yr. CAGR % | 27.47 | 33.9 | 19.96 | 22.31 | 5.79 | |||||
Inventory, 3 Yr. CAGR % | 53.61 | 40.09 | 22.29 | -4.54 | 12.95 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -3.16 | 0.44 | 16.13 | 24.29 | 11.74 | |||||
Total Assets, 3 Yr. CAGR % | 24.82 | 22.14 | 17.23 | 3.33 | 0.35 | |||||
Tangible Book Value, 3 Yr. CAGR % | 44.8 | 39.05 | 32.17 | 2.04 | -3.23 | |||||
Common Equity, 3 Yr. CAGR % | 26.65 | 25.26 | 21.05 | 3.62 | -1.05 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.64 | 1.26 | 21.81 | -16.52 | -13.33 | |||||
Capital Expenditures, 3 Yr. CAGR % | 60.7 | 19.49 | 38.58 | 24.09 | 8.4 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -27.06 | 34.38 | 53.23 | 244.6 | 4.13 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -23.8 | 40.46 | 58.12 | 314.97 | 4.18 | |||||
Dividend Per Share, 3 Yr. CAGR % | 10.54 | 20.61 | -24.35 | -24.35 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 30.83 | 28.19 | 5.78 | 4.6 | -0.78 | |||||
Gross Profit, 5 Yr. CAGR % | 33.81 | 30.8 | 5.91 | 3.26 | -4.82 | |||||
EBITDA, 5 Yr. CAGR % | 58.46 | 63.03 | -5.23 | -20.66 | -20.69 | |||||
EBITA, 5 Yr. CAGR % | 61.92 | 68.25 | -5.77 | -23.29 | -16.28 | |||||
EBIT, 5 Yr. CAGR % | 62.03 | 68.77 | -6.37 | -24.66 | -14.75 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 46.58 | 43.91 | -24.55 | -26.98 | -12.09 | |||||
Net Income, 5 Yr. CAGR % | 46.24 | 45.66 | -23.55 | -29.63 | -11.19 | |||||
Normalized Net Income, 5 Yr. CAGR % | 45.79 | 46.71 | -3.97 | -22.16 | -20.26 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 37.02 | 38.49 | -24.18 | -33.05 | -13.19 | |||||
Accounts Receivable, 5 Yr. CAGR % | 32.75 | 34.52 | 27.48 | 23.92 | 13.58 | |||||
Inventory, 5 Yr. CAGR % | 58.49 | 40.28 | 23.94 | 26.49 | 19.27 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 18.82 | 7.48 | 5.84 | 10.85 | 11.67 | |||||
Total Assets, 5 Yr. CAGR % | 42.66 | 37.7 | 16.47 | 13.47 | 9.57 | |||||
Tangible Book Value, 5 Yr. CAGR % | 35.91 | 35.2 | 26.95 | 20.43 | 16.79 | |||||
Common Equity, 5 Yr. CAGR % | 47.22 | 44.47 | 17.65 | 14.69 | 11.28 | |||||
Cash From Operations, 5 Yr. CAGR % | 71.16 | 8.17 | -3.76 | -1.44 | 7.44 | |||||
Capital Expenditures, 5 Yr. CAGR % | 29.22 | 10.74 | 45.27 | 28.53 | 15.11 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -10.24 | -0.44 | 26.85 | 48.04 | 24.65 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -7.25 | -0.57 | 25.76 | 52.18 | 27.17 | |||||
Dividend Per Share, 5 Yr. CAGR % | 22.13 | 11.9 | -10.17 | -10.17 | - |
- Stock Market
- Equities
- 300451 Stock
- Financials B-SOFT Co.,Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















